Skip to main content

Table 1 Study schemaa and evaluable modified intent-to-treat population

From: Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm

  Visit 1 (screening, Week 0) Visit 2 (end of no-drug qualification period, Week 4) Visit 5 (end of single-blind placebo treatment period, Week 10) Visit 12 (end of double-blind treatment period, Week 23)
Evaluable mITT N = 325 N = 324 N = 238 N = 229
FSDS-DAO X X X X
FSFI X X X X
GAQ    X X
WITS-9    X X
  1. FSDS-DAO = Female Sexual Distress Scale-Desire/Arousal/Orgasm; FSFI = Female Sexual Function Index; GAQ = General Assessment Questionnaire; mITT = modified intent-to-treat; WITS-9 = Women’s Inventory of Treatment Satisfaction
  2. aThe FSEP-R was completed after each sexual encounter